R3NK:XETRRENK Group AG Analysis
Data as of 2026-09-11 - not real-time
€42.03
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
At €42.02, RENK Group AG shows a bearish moving-average alignment, with shorter averages beneath longer ones. It has lost 11.9% over the past 30 days. Momentum indicators put RSI at 33.0 (approaching oversold) with MACD reading bearish. Recent trading has carved out support near €41.67 and resistance around €52.46.
Valuation screens as overvalued: a P/E of 42.4 sits above the sector average of 27.7. Sell-side targets cluster 51.1% above the current quote. The 1.35% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 37.0%, a beta of 0.30 and a maximum drawdown of 53.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 2/10 conviction over the longer horizon.
Valuation screens as overvalued: a P/E of 42.4 sits above the sector average of 27.7. Sell-side targets cluster 51.1% above the current quote. The 1.35% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 37.0%, a beta of 0.30 and a maximum drawdown of 53.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 2/10 conviction over the longer horizon.
Top Market Events
Renk Group AG / Keyword: Mergers and Acquisitions / Purchase of parts of a company Renk Group AG: RENK Enters Into...RENK Group AG's Supervisory Board has extended CEO Dr.RENK Group AG shares on Xetra traded broadly stable on 06/02/2026 as investors look ahead to the Ger
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 51.65
- MACD momentum is negative
Medium Term
1–3 yearsCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 42.4 versus sector average of 27.7
- Trading below the 200-day average of 51.65
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 42.4 versus sector average of 27.7
- Analyst targets imply +51.1% versus the current price
- Return on equity of 22.6%
Key Metrics & Analysis
Financial Health
Revenue Growth1.70%
Profit Margin7.17%
P/E Ratio42.4
ROE22.57%
ROA6.29%
Debt/Equity112.55
P/B Ratio9.0
Op. Cash Flow€167.8M
Free Cash Flow€68.1M
Industry P/E27.7
Technical Analysis
TrendBearish
RSI33.0
Support€41.67
Resistance€52.46
MA 20€46.47
MA 50€46.70
MA 200€51.65
MACDBearish
VolumeIncreasing
Fear & Greed Index90.29
Valuation
Fair Value€5.27
Target Price€63.51
Upside/Downside51.11%
GradeOvervalued
TypeBlend
Dividend Yield1.35%
Risk Assessment
Beta0.30
Volatility36.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.